Dianthus Therapeutics (DNTH) Assets Average (2018 - 2025)

Dianthus Therapeutics' Assets Average history runs 8 years deep, the most recent figure standing at $554.2 million for Q4 2025.

• In Q4 2025, Assets Average rose 52.19% year-over-year to $554.2 million; the TTM figure through Dec 2025 stood at $554.2 million (up 52.19% YoY), while the FY2025 annual figure was $452.5 million, up 63.52% from the prior year.
• Assets Average was $554.2 million for Q4 2025 at Dianthus Therapeutics, up from $451.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $554.2 million in Q4 2025 to a low of $81.0 million in Q2 2023.
• Historically, Assets Average has averaged $249.5 million across 5 years, with a median of $195.1 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Assets Average tumbled 56.66% in 2023, then surged 363.61% in 2024.
• A 5-year view of Assets Average shows it stood at $198.1 million in 2021, then sank by 37.59% to $123.6 million in 2022, then jumped by 50.41% to $185.9 million in 2023, then jumped by 95.84% to $364.1 million in 2024, then surged by 52.19% to $554.2 million in 2025.
• The last three Assets Average figures came in at $554.2 million (Q4 2025), $451.8 million (Q3 2025), and $337.3 million (Q2 2025), per Business Quant data.